Total Credits: .75
Tags: Live
Our tenth of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.
There is no live Q&A with faculty associated with this program. This course is available to watch on-demand and receive 0.75 credit until August 31, 2021. View the Accreditation Statement/Credit tab for additional details.
What’s New on the Horizon for Thyroid Cancer? (Maria E. Cabanillas, MD, FACE)
Learning Objectives:
Discuss the latest innovations in advanced thyroid cancer
Ethics of Novel Technologies and Surgical Approaches (Peter Angelos, MD, PhD, FACS)
Learning Objectives:
Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.
American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).
Accreditation Statement/Credit
Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.
Disclosure Statement
The faculty did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation
Completion of Learning Assessment by Participant |
Credit Disseminated (CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded) |
May 29, 2020 – August 31, 2020 |
September 15, 2020 |
September 1, 2020 – November 30, 2020 |
December 15, 2020 |
December 1, 2020 – February 28, 2021 |
March 15, 2021 |
March 1, 2021 – May 31, 2021 |
June 15, 2021 |
June 1, 2021 – August 31, 2021 |
September 15, 2021 |
Maria E. Cabanillas, MD is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson. As a clinician and clinical researcher, she treats both early and advanced thyroid cancers, including medullary, differentiated, and anaplastic thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer and is an IRB vice-chair. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and is currently on the Board of Directors.
Peter Angelos, MD, PhD, FACS is a Linda Kohler Anderson Professor of Surgery and Surgical Ethics, Chief of Endocrine Surgery, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago Medicine. He completed his undergraduate degree, medical school, and a Ph.D. in Philosophy at Boston University. He completed his residency in General Surgery at Northwestern University and went on to complete fellowships in Clinical Ethics at the University of Chicago and in Endocrine Surgery at the University of Michigan. Dr. Angelos has written widely on improving outcomes of thyroid and parathyroid surgery, minimally invasive endocrine surgery, and ethical aspects in the care of surgical patients.
Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.
Disclosure Statement
The faculty did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation
Completion of Learning Assessment by Participant |
Credit Disseminated (CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded) |
May 29, 2020 – August 31, 2020 |
September 15, 2020 |
September 1, 2020 – November 30, 2020 |
December 15, 2020 |
December 1, 2020 – February 28, 2021 |
March 15, 2021 |
March 1, 2021 – May 31, 2021 |
June 15, 2021 |
June 1, 2021 – August 31, 2021 |
September 15, 2021 |